Clinical Trial Update: Organ Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating dose-escalated MR-guided adaptive radiotherapy for organ preservation in rectal cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Rectal Cancer | Phase 2 | Status: RECRUITING